1.1.1.1 alcohol dehydrogenase hepatoma cell - 686331 1.1.1.153 sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) hepatoma cell - 762356 1.1.1.205 IMP dehydrogenase hepatoma cell - 347916 1.1.1.211 long-chain-3-hydroxyacyl-CoA dehydrogenase hepatoma cell - 761287 1.1.1.271 GDP-L-fucose synthase hepatoma cell the enzyme is aberrantly upregulated in human hepatoma 762887 1.1.1.300 NADP-retinol dehydrogenase hepatoma cell reduced RDH11 expression level compared to hepatocytes 761488 1.1.1.40 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) hepatoma cell - 761332 1.1.1.41 isocitrate dehydrogenase (NAD+) hepatoma cell - 712180 1.1.1.42 isocitrate dehydrogenase (NADP+) hepatoma cell - 712180 1.11.1.12 phospholipid-hydroperoxide glutathione peroxidase hepatoma cell - 725172 1.11.1.9 glutathione peroxidase hepatoma cell - 688957 1.13.11.53 acireductone dioxygenase (Ni2+-requiring) hepatoma cell - 764433 1.14.11.16 peptide-aspartate beta-dioxygenase hepatoma cell - 673915, 675183, 675861 1.14.11.16 peptide-aspartate beta-dioxygenase hepatoma cell highly expressed in 4 of 10 hepatocarcinomas, 10-fold activity increase 439254 1.14.11.66 [histone H3]-trimethyl-L-lysine9 demethylase hepatoma cell - 745949, 756531 1.14.11.69 [histone H3]-trimethyl-L-lysine36 demethylase hepatoma cell - 745949 1.14.14.18 heme oxygenase (biliverdin-producing) hepatoma cell overexpression of HO-1 -, 687147 1.14.19.1 stearoyl-CoA 9-desaturase hepatoma cell - 746433 1.14.99.38 cholesterol 25-monooxygenase hepatoma cell - 745051 1.14.99.66 [histone H3]-N6,N6-dimethyl-L-lysine4 FAD-dependent demethylase hepatoma cell - 698198 1.17.4.1 ribonucleoside-diphosphate reductase hepatoma cell - 745050 1.2.1.105 2-oxoglutarate dehydrogenase system hepatoma cell - 349006 1.2.1.12 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) hepatoma cell - -, 742477 1.2.1.36 retinal dehydrogenase hepatoma cell - 763150 1.2.4.1 pyruvate dehydrogenase (acetyl-transferring) hepatoma cell - 700236 1.3.1.21 7-dehydrocholesterol reductase hepatoma cell - 740913 1.4.1.27 glycine cleavage system hepatoma cell - 759374 1.4.3.13 protein-lysine 6-oxidase hepatoma cell - 684931 1.5.1.2 pyrroline-5-carboxylate reductase hepatoma cell - 392128 1.5.8.4 dimethylglycine dehydrogenase hepatoma cell - 743378 1.8.1.9 thioredoxin-disulfide reductase hepatoma cell - 677195 1.8.4.12 peptide-methionine (R)-S-oxide reductase hepatoma cell MsrB1 is highly expressed in HCC tissues and its expression correlates with the prognoses of patients with HCC after hepatectomy 765497 2.1.1.17 phosphatidylethanolamine N-methyltransferase hepatoma cell enzyme form PEMT2 is absent in hepatoma cells growing exponentially in vivo. Both PEMT2 and mRNA appears when cells enter the stationary phase of tumor growth 485189 2.1.1.17 phosphatidylethanolamine N-methyltransferase hepatoma cell PEMT2 protein decreases in preneoplastic nodules and virtually disappears in hepatocellular carcinoma 485195 2.1.1.5 betaine-homocysteine S-methyltransferase hepatoma cell - 673003 2.1.2.5 glutamate formimidoyltransferase hepatoma cell DU249 chicken hepatoma cells, contain p60 but no measurable formiminotransferase activity, may be due to the low expression of p60 34325 2.1.3.3 ornithine carbamoyltransferase hepatoma cell - 757879 2.3.1.26 sterol O-acyltransferase hepatoma cell - 486677, 684882 2.3.1.42 glycerone-phosphate O-acyltransferase hepatoma cell - 756338 2.3.1.48 histone acetyltransferase hepatoma cell - 756850, 757011 2.3.1.48 histone acetyltransferase hepatoma cell tissue culture cell, HTC cells 487078 2.3.1.57 diamine N-acetyltransferase hepatoma cell - 701662, 757889 2.3.1.B41 protein-long-chain fatty-acyl-lysine deacylase (NAD+) hepatoma cell - 757883 2.3.1.B41 protein-long-chain fatty-acyl-lysine deacylase (NAD+) hepatoma cell HCC cell, SIRT6 upregulation is quite prevalent in HCC tissues and closely correlated with worse overall survival, disease-relapse free survival, and HCC metastasis 757530 2.3.1.B41 protein-long-chain fatty-acyl-lysine deacylase (NAD+) hepatoma cell increased SIRT6 expression in HCC, SIRT6 expression pattern and its association with HCC metastasis, overview 757644 2.3.2.2 gamma-glutamyltransferase hepatoma cell azo dye-induced 487913 2.3.2.2 gamma-glutamyltransferase hepatoma cell primary and Yoshida ascites (AH 13) 487912 2.3.2.5 glutaminyl-peptide cyclotransferase hepatoma cell - 759074 2.4.1.101 alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase hepatoma cell diethylnitrosamine- or dimethylaminoazobenzene-induced hepatoma, Morris 5123D hepatoma or AH-109A, solid or ascitic 488363 2.4.1.133 xylosylprotein 4-beta-galactosyltransferase hepatoma cell - 704930 2.4.1.144 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase hepatoma cell - 488370, 637308, 638223, 638224, 638227, 736507 2.4.1.144 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase hepatoma cell 7721 cells, activity during cell-cycle 638226 2.4.1.144 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase hepatoma cell low activity 638223 2.4.1.144 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase hepatoma cell primary, about 100fold increased activity compared to normal liver tissue 638223 2.4.1.145 alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase hepatoma cell - 722374 2.4.1.155 alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase hepatoma cell - 675946, 759648 2.4.1.255 protein O-GlcNAc transferase hepatoma cell the level of total O-GlcNAcylation or O-GlcNAc transferase protein is increased in hepatocellular carcinoma 759542 2.4.1.38 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase hepatoma cell - 657750, 688952 2.4.1.65 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase hepatoma cell - 662544 2.4.1.68 glycoprotein 6-alpha-L-fucosyltransferase hepatoma cell - 489333 2.4.1.68 glycoprotein 6-alpha-L-fucosyltransferase hepatoma cell DAB-induced hepatoma 489333 2.4.1.68 glycoprotein 6-alpha-L-fucosyltransferase hepatoma cell expression in hepatoma tissues and their surrounding tissues and in tissues with chronic disease, overview 489339 2.4.1.69 type 1 galactoside alpha-(1,2)-fucosyltransferase hepatoma cell e.g. hepatoma H35 cells, the enzyme is induced during early stages of chemical hepatocarcinogenesis in parenchymal cells of Fischer 344 rats fed a diet supplemented with 0.03% N-2-acetylaminofluorene, undetectable in normal liver tissue 489357 2.4.1.90 N-acetyllactosamine synthase hepatoma cell Hep-G2 cells 658123 2.4.2.10 orotate phosphoribosyltransferase hepatoma cell OPRT is involved in early events of invasion of hepatocellular carcinoma cells 676296 2.4.2.12 nicotinamide phosphoribosyltransferase hepatoma cell - 735872 2.4.2.30 NAD+ ADP-ribosyltransferase hepatoma cell - 736899 2.4.2.31 NAD+-protein-arginine ADP-ribosyltransferase hepatoma cell - 638116 2.4.3.1 beta-galactoside alpha-(2,6)-sialyltransferase hepatoma cell - 759660, 764855 2.5.1.18 glutathione transferase hepatoma cell - 637909, 637921 2.5.1.21 squalene synthase hepatoma cell - 658266, 738940 2.5.1.22 spermine synthase hepatoma cell - 489869 2.5.1.6 methionine adenosyltransferase hepatoma cell - 686924, 686926 2.6.1.13 ornithine aminotransferase hepatoma cell - 759413 2.6.1.44 alanine-glyoxylate transaminase hepatoma cell - 759686 2.6.1.51 serine-pyruvate transaminase hepatoma cell - 759686 2.7.1.1 hexokinase hepatoma cell - 704456 2.7.1.1 hexokinase hepatoma cell type II isozyme 662531 2.7.1.105 6-phosphofructo-2-kinase hepatoma cell - 761915 2.7.1.105 6-phosphofructo-2-kinase hepatoma cell resembles muscle enzyme 94932 2.7.1.107 diacylglycerol kinase (ATP) hepatoma cell - 761306 2.7.1.12 gluconokinase hepatoma cell - 762082 2.7.1.137 phosphatidylinositol 3-kinase hepatoma cell Fao hepatoma cells 640913 2.7.1.171 protein-fructosamine 3-kinase hepatoma cell - 760823 2.7.1.171 protein-fructosamine 3-kinase hepatoma cell overexpression 762465 2.7.1.48 uridine/cytidine kinase hepatoma cell - 761333 2.7.1.48 uridine/cytidine kinase hepatoma cell hepatoma 3924A cells, 2fold increase in activity during early log phase of prolifration 641653 2.7.1.48 uridine/cytidine kinase hepatoma cell UCK2 is significantly upregulated in hepatocellular carcinoma tissues compared to adjacent normal tissues 761333 2.7.1.48 uridine/cytidine kinase hepatoma cell UCKL1 is significantly upregulated in hepatocellular carcinoma tissues compared to adjacent normal tissues 761333 2.7.1.91 sphingosine kinase hepatoma cell - 671356, 673271 2.7.10.1 receptor protein-tyrosine kinase hepatoma cell - 490387 2.7.10.2 non-specific protein-tyrosine kinase hepatoma cell - 490349, 661445, 661461 2.7.10.2 non-specific protein-tyrosine kinase hepatoma cell HCC cell 691651 2.7.11.1 non-specific serine/threonine protein kinase hepatoma cell - 491119, 661422, 661900 2.7.11.10 IkappaB kinase hepatoma cell - 662516 2.7.11.12 cGMP-dependent protein kinase hepatoma cell - 693879 2.7.11.13 protein kinase C hepatoma cell constitutively active isozyme PKCdelta 676029 2.7.11.17 Ca2+/calmodulin-dependent protein kinase hepatoma cell - 664865 2.7.11.19 phosphorylase kinase hepatoma cell - 761283 2.7.11.2 [pyruvate dehydrogenase (acetyl-transferring)] kinase hepatoma cell - 660642, 660896, 674730, 760485